BioAtla, Inc. (NASDAQ: BCAB) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.
BioAtla Inc (BCAB) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress [Yahoo! Finance]
BioAtla Reports Third Quarter 2024 Financial Results and Highlights Recent Progress
BioAtla to Announce Third Quarter 2024 Financial Results and Provide Business Highlights on November 7, 2024